Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China
· Delayed Price · Currency is CNY 54.16
-2.53 (-4.46%)
May 23, 2025, 2:45 PM CST
SHA:688336 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 716.42 | 704.58 | 294.61 | 49.3 | 18.06 | -217.46 | Upgrade
|
| Depreciation & Amortization | 127.51 | 127.51 | 96.08 | 122.41 | 135.46 | 136.02 | Upgrade
|
| Other Amortization | 0.46 | 0.46 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.12 | -0.12 | -56.39 | 0.94 | 12.98 | 0.47 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 16 | Upgrade
|
| Loss (Gain) From Sale of Investments | -411.59 | -411.59 | -3 | -19.98 | -20.93 | -18.01 | Upgrade
|
| Stock-Based Compensation | 6.97 | 6.97 | -6.28 | 2.54 | 11.42 | 0.51 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.23 | -0.23 | -6.79 | 5.49 | 1.22 | -4.25 | Upgrade
|
| Other Operating Activities | -91.34 | -77.49 | -35.91 | 3.68 | -20.61 | 56.28 | Upgrade
|
| Change in Accounts Receivable | -60.93 | -60.93 | 15.4 | 107.1 | -258.94 | 196.63 | Upgrade
|
| Change in Inventory | -35.01 | -35.01 | 33.36 | - | - | -109.06 | Upgrade
|
| Change in Accounts Payable | 17.83 | 17.83 | 63.46 | 9.24 | -67.49 | -34.82 | Upgrade
|
| Change in Unearned Revenue | -7.09 | -7.09 | -5.46 | -10.49 | -18.83 | -12.37 | Upgrade
|
| Operating Cash Flow | 279.13 | 281.14 | 416.35 | 233.49 | -243.79 | -40.08 | Upgrade
|
| Operating Cash Flow Growth | -39.50% | -32.48% | 78.32% | - | - | - | Upgrade
|
| Capital Expenditures | -263.98 | -280.78 | -235.75 | -221.26 | -263.82 | -226.98 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.69 | 0.69 | 100.45 | 0.4 | 0.38 | 0.03 | Upgrade
|
| Investment in Securities | -579.04 | -953.98 | -366.5 | -725.89 | 214 | -333 | Upgrade
|
| Other Investing Activities | 491.53 | 483.93 | 22.37 | 30.06 | 30.94 | 30.36 | Upgrade
|
| Investing Cash Flow | -350.81 | -750.14 | -479.42 | -916.69 | -18.5 | -529.6 | Upgrade
|
| Short-Term Debt Issued | - | 50 | 50 | 150 | - | - | Upgrade
|
| Total Debt Issued | 50 | 50 | 50 | 150 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -50 | -150 | - | - | - | Upgrade
|
| Total Debt Repaid | -50 | -50 | -150 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -100 | 150 | - | - | Upgrade
|
| Issuance of Common Stock | - | - | - | 2.3 | - | 1,886 | Upgrade
|
| Common Dividends Paid | -52.35 | -52.37 | -1.47 | -1.22 | - | - | Upgrade
|
| Other Financing Activities | - | - | - | - | - | -21.3 | Upgrade
|
| Financing Cash Flow | -52.35 | -52.37 | -101.47 | 151.08 | - | 1,864 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.39 | 0.28 | 2.27 | 1.47 | -0.17 | -13.25 | Upgrade
|
| Net Cash Flow | -123.63 | -521.1 | -162.27 | -530.66 | -262.47 | 1,281 | Upgrade
|
| Free Cash Flow | 15.15 | 0.35 | 180.61 | 12.23 | -507.61 | -267.06 | Upgrade
|
| Free Cash Flow Growth | -94.88% | -99.80% | 1376.67% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 1.22% | 0.03% | 17.81% | 1.48% | -54.65% | -40.77% | Upgrade
|
| Free Cash Flow Per Share | 0.03 | 0.00 | 0.29 | 0.02 | -0.84 | -0.45 | Upgrade
|
| Cash Income Tax Paid | 42.7 | 43.1 | 29.24 | 24.57 | 21.75 | 67.58 | Upgrade
|
| Levered Free Cash Flow | -598.58 | -66.63 | 46.51 | -14.48 | -394.76 | -78 | Upgrade
|
| Unlevered Free Cash Flow | -597.86 | -65.9 | 47.38 | -13.66 | -394.76 | -78 | Upgrade
|
| Change in Net Working Capital | 600.3 | 49.16 | -73.82 | -106.09 | 209.81 | -173.05 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.